107 related articles for article (PubMed ID: 19922830)
21. Validation of a 4D-PET maximum intensity projection for delineation of an internal target volume.
Callahan J; Kron T; Schneider-Kolsky M; Dunn L; Thompson M; Siva S; Aarons Y; Binns D; Hicks RJ
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):749-54. PubMed ID: 23601897
[TBL] [Abstract][Full Text] [Related]
22. False-positive 18-fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET/CT) scans mimicking malignancies.
Yasar Z; Acat M; Onaran H; H Dincer E; Cetinkaya E; A Korkmaz N; Ozgül A
Med Glas (Zenica); 2015 Feb; 12(1):40-6. PubMed ID: 25669335
[TBL] [Abstract][Full Text] [Related]
23. Generation of 4-dimensional CT images based on 4-dimensional PET-derived motion fields.
Fayad HJ; Lamare F; Le Rest CC; Bettinardi V; Visvikis D
J Nucl Med; 2013 Apr; 54(4):631-8. PubMed ID: 23471313
[TBL] [Abstract][Full Text] [Related]
24. Dual-phase 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5.
Chen CJ; Lee BF; Yao WJ; Cheng L; Wu PS; Chu CL; Chiu NT
AJR Am J Roentgenol; 2008 Aug; 191(2):475-9. PubMed ID: 18647920
[TBL] [Abstract][Full Text] [Related]
25. The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions.
Lan XL; Zhang YX; Wu ZJ; Jia Q; Wei H; Gao ZR
Clin Radiol; 2008 Jul; 63(7):756-64. PubMed ID: 18555033
[TBL] [Abstract][Full Text] [Related]
26. Biopsy findings in PET/CT-positive lung lesions in a community hospital.
Lobrano MB; Hayman E; Dekelbaum M; Campeau R
J La State Med Soc; 2005; 157(6):319-24. PubMed ID: 16579344
[TBL] [Abstract][Full Text] [Related]
27. Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions.
Imdahl A; Jenkner S; Brink I; Nitzsche E; Stoelben E; Moser E; Hasse J
Eur J Cardiothorac Surg; 2001 Aug; 20(2):324-9. PubMed ID: 11463551
[TBL] [Abstract][Full Text] [Related]
28. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
[TBL] [Abstract][Full Text] [Related]
29. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.
Strobel K; Dummer R; Husarik DB; Pérez Lago M; Hany TF; Steinert HC
Radiology; 2007 Aug; 244(2):566-74. PubMed ID: 17641374
[TBL] [Abstract][Full Text] [Related]
30. The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.
Shin DS; Shon OJ; Han DS; Choi JH; Chun KA; Cho IH
Ann Nucl Med; 2008 Aug; 22(7):603-9. PubMed ID: 18756363
[TBL] [Abstract][Full Text] [Related]
31. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
Delbeke D; Rose DM; Chapman WC; Pinson CW; Wright JK; Beauchamp RD; Shyr Y; Leach SD
J Nucl Med; 1999 Nov; 40(11):1784-91. PubMed ID: 10565771
[TBL] [Abstract][Full Text] [Related]
32. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
[TBL] [Abstract][Full Text] [Related]
33. Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules.
Higashi K; Ueda Y; Sakuma T; Seki H; Oguchi M; Taniguchi M; Taki S; Tonami H; Katsuda S; Yamamoto I
J Nucl Med; 2001 Oct; 42(10):1489-96. PubMed ID: 11585862
[TBL] [Abstract][Full Text] [Related]
34. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET.
Yun M; Choi HS; Yoo E; Bong JK; Ryu YH; Lee JD
J Nucl Med; 2005 Jun; 46(6):953-7. PubMed ID: 15937305
[TBL] [Abstract][Full Text] [Related]
35. Differential diagnosis of pulmonary lesions by parametric imaging in (18)F-FDG PET/CT dynamic multi-bed scanning.
Wang Q; Wang RF; Zhang J; Zhou Y
J BUON; 2013; 18(4):928-34. PubMed ID: 24344019
[TBL] [Abstract][Full Text] [Related]
36. The effect of 18F-FDG-PET/CT respiratory gating on detected metabolic activity in lung lesions.
Lupi A; Zaroccolo M; Salgarello M; Malfatti V; Zanco P
Ann Nucl Med; 2009 Feb; 23(2):191-6. PubMed ID: 19225943
[TBL] [Abstract][Full Text] [Related]
37. Limitations of dual time point PET in the assessment of lung nodules with low FDG avidity.
Cloran FJ; Banks KP; Song WS; Kim Y; Bradley YC
Lung Cancer; 2010 Apr; 68(1):66-71. PubMed ID: 19559496
[TBL] [Abstract][Full Text] [Related]
38. Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis.
Perri M; Erba P; Volterrani D; Guidoccio F; Lazzeri E; Caramella D; Mariani G
AJR Am J Roentgenol; 2011 Jul; 197(1):209-16. PubMed ID: 21701032
[TBL] [Abstract][Full Text] [Related]
39. Impact of free-breathing CT on quantitative measurements of static and quiescent period-gated PET Images.
Meier JG; Einstein SA; Diab RH; Erasmus LJ; Xu G; Mawlawi OR
Phys Med Biol; 2019 May; 64(10):105013. PubMed ID: 31026840
[TBL] [Abstract][Full Text] [Related]
40. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study.
Tournoy KG; Maddens S; Gosselin R; Van Maele G; van Meerbeeck JP; Kelles A
Thorax; 2007 Aug; 62(8):696-701. PubMed ID: 17687098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
